{"doi":"10.1101/2020.02.25.965004","title":"An NKX2-1/ERK/WNT feedback loop modulates gastric identity and response to targeted therapy in lung adenocarcinoma","abstract":"ABSTRACT Cancer cells undergo lineage switching during natural progression and in response to therapy. NKX2-1 loss in human and murine lung adenocarcinoma leads to invasive mucinous adenocarcinoma (IMA), a lung cancer subtype that exhibits gastric differentiation and harbors a distinct spectrum of driver oncogenes. NKX2-1 is required for optimal tumor initiation, but dispensable for growth of established tumors, in BRAF V600E driven disease. NKX2-1-deficient, BRAF V600E driven tumors resemble human IMA and exhibit a distinct response to BRAF/MEK inhibitors. Whereas BRAF/MEK inhibitors drive NKX2-1-positive tumor cells into quiescence, NKX2-1-negative cells fail to exit the cell cycle after the same therapy. BRAF/MEK inhibitors also induce cell identity switching in NKX2-1-negative lung tumors within the gastric lineage, which is driven in part by WNT signaling and FoxA1/2. These data elucidate a complex, reciprocal relationship between lineage specifiers and oncogenic signaling pathways in the regulation of lung adenocarcinoma identity that is likely to impact lineage-specific therapeutic strategies.","journal":"bioRxiv (Cold Spring Harbor Laboratory)","year":2020,"id":123491,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":3,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9446,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2020-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":566369,"name":"Elnaz Mirzaei Mehrabad","orcid":"0000-0002-0393-0428","position":1,"is_corresponding":false},{"id":566810,"name":"Kelley Ingram","orcid":null,"position":2,"is_corresponding":false},{"id":566370,"name":"Pengshu Fang","orcid":"0000-0002-4645-6869","position":3,"is_corresponding":false},{"id":566811,"name":"Katherine L. Gillis","orcid":null,"position":4,"is_corresponding":false},{"id":566812,"name":"Soledad A. Camolotto","orcid":null,"position":5,"is_corresponding":false},{"id":566813,"name":"Grace Orstad","orcid":null,"position":6,"is_corresponding":false},{"id":74683,"name":"Alex Jones","orcid":null,"position":7,"is_corresponding":false},{"id":566371,"name":"Michelle C. Mendoza","orcid":"0000-0002-6490-1794","position":8,"is_corresponding":false},{"id":566372,"name":"Benjamin T. Spike","orcid":"0000-0002-0893-3302","position":9,"is_corresponding":false},{"id":71716,"name":"Eric L. Snyder","orcid":"0000-0003-3591-3195","position":10,"is_corresponding":false},{"id":566809,"name":"Rediet Zewdu","orcid":null,"position":0,"is_corresponding":true}],"reference_count":101,"raw_metadata":null,"created_at":"2026-07-18T23:14:59.547352Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}